The mystery of motor asymmetry in Parkinson's disease (Q36568001)

15 August 2017

1 reference

title

The mystery of motor asymmetry in Parkinson's disease (English)

1 reference

15 August 2017

1 reference

Ruth Djaldetti

1

1 reference

15 August 2017

Ilan Ziv

series ordinal

2

1 reference

15 August 2017

Eldad Melamed

series ordinal

3

1 reference

15 August 2017

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

5

1 reference

15 August 2017

issue

9

1 reference

15 August 2017

page(s)

796-802

1 reference

Parkinsonism: onset, progression, and mortality

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Diagnostic criteria for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Anomalies of asymmetry of clinical signs in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Survival study of Parkinson disease in Olmsted County, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The metabolic anatomy of Parkinson's disease: Complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Clinical and [18F] dopa PET findings in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

[11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Genetics of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Genetics of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Clinical genetic analysis of Parkinson's disease in the Contursi kindred

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

PET neuroimaging and mutations in the DJ-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Familial Parkinson's disease: clinical and genetic analysis of four Basque families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Primary sensory symptoms in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Painful Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Quantitative measurement of pain sensation in patients with Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Fatigue in Parkinson's disease: a nine-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

1 reference

7 January 2021

Sympathetic skin response asymmetry in early stage idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Abnormal skin wrinkling in the less affected side in hemiparkinsonism-a possible test for sympathetic dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The number of nerve cells in the substantia nigra in paralysis agitans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Parkinson's disease in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Parkinson's disease in 65 pairs of twins and in a set of quadruplets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Parkinson disease: handedness predicts asymmetry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Side of onset of motor symptoms influences cognition in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Functional magnetic resonance imaging of motor cortex: hemispheric asymmetry and handedness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Is idiopathic parkinsonism the consequence of an event or a process?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Genetic and environmental factors in the cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Clinical characteristics of neuroleptic-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

Time and chance: the stochastic nature of disease causation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970549-X

7 January 2021

10.1016/S1474-4422(06)70549-X

Identifiers

DOI

1 reference

15 August 2017

1 reference